NDC properties for "timolol 20 MG (as maleate) Oral Tablet" (RxCUI 198285)
About this data
The tables show NDC propoerties for timolol 20 MG (as maleate) Oral Tablet with the RxCUI 198285
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for timolol 20 MG (as maleate) Oral Tablet (RxCUI 198285)
| ANDA | ANDA072668 |
|---|---|
| ANDA | ANDA207556 |
| MMSL_CODE | BD3333 |
| MMSL_CODE | CD3333 |
| RxCUI | 198285 |
| SNOMEDCT | 376776002 |
| SPL_SET_ID | 0bc40b2c-65eb-4095-87e6-4752d5b19a3a |
| SPL_SET_ID | 57c62928-63d8-4505-9b9e-c085a3a12c95 |
| SPL_SET_ID | d591352a-09d8-2fdc-e053-2a95a90ad8a5 |
| VUID | 4002850 |
| Prescribable Synonym | timolol maleate 20 MG Oral Tablet |
| RXNAV_STR | timolol 20 MG Oral Tablet |
| RxNorm Name | timolol 20 MG Oral Tablet |
| RxNorm Synonym | timolol 20 MG (as maleate) Oral Tablet |
| Related queries | Interactions (for RxCUI 198285) |
NDC Properties
NDC Item 00378071501
| NDC 9 | 0378-0715 |
|---|---|
| NDC 10 | 0378-0715-01 |
| NDC Item | 00378071501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0715-01) |
| ANDA | ANDA072668 |
| COLORTEXT | GREEN |
| Color | C48329 __ |
| FDA SPL set id | 610516 |
| Imprint code | M;715 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-06-08 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule-shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 0378-0715 |
NDC Item 13811062010
| NDC 9 | 13811-620 |
|---|---|
| NDC 10 | 13811-620-10 |
| NDC Item | 13811062010 |
| Packaging | 100 TABLET in 1 BOTTLE (13811-620-10) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 542380 |
| Imprint code | IT;72 |
| Labeler | Trigen Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-11-30 |
| Marketing effective time low | 2019-05-06 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 13811-620 |
NDC Item 16571022501
| NDC 9 | 16571-225 |
|---|---|
| NDC 10 | 16571-225-01 |
| NDC Item | 16571022501 |
| Packaging | 100 TABLET in 1 BOTTLE (16571-225-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 839159 |
| Imprint code | IT;72 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-12-10 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 16571-225 |
NDC Item 73152003101
| NDC 9 | 73152-031 |
|---|---|
| NDC 10 | 73152-031-01 |
| NDC Item | 73152003101 |
| Packaging | 100 TABLET in 1 BOTTLE (73152-031-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 630369 |
| Imprint code | IT;72 |
| Labeler | Athem LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 73152-031 |
NDC Item 00378071501
| NDC 9 | 0378-0715 |
|---|---|
| NDC 10 | 0378-0715-01 |
| NDC Item | 00378071501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0715-01) |
| ANDA | ANDA072668 |
| COLORTEXT | GREEN |
| Color | C48329 __ |
| FDA SPL set id | 610516 |
| Imprint code | M;715 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-06-08 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule-shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 0378-0715 |
NDC Item 13811062010
| NDC 9 | 13811-620 |
|---|---|
| NDC 10 | 13811-620-10 |
| NDC Item | 13811062010 |
| Packaging | 100 TABLET in 1 BOTTLE (13811-620-10) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 542380 |
| Imprint code | IT;72 |
| Labeler | Trigen Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-11-30 |
| Marketing effective time low | 2019-05-06 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 13811-620 |
NDC Item 16571022501
| NDC 9 | 16571-225 |
|---|---|
| NDC 10 | 16571-225-01 |
| NDC Item | 16571022501 |
| Packaging | 100 TABLET in 1 BOTTLE (16571-225-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 839159 |
| Imprint code | IT;72 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-12-10 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 16571-225 |
NDC Item 73152003101
| NDC 9 | 73152-031 |
|---|---|
| NDC 10 | 73152-031-01 |
| NDC Item | 73152003101 |
| Packaging | 100 TABLET in 1 BOTTLE (73152-031-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 630369 |
| Imprint code | IT;72 |
| Labeler | Athem LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 73152-031 |
NDC Item 00378071501
| NDC 9 | 0378-0715 |
|---|---|
| NDC 10 | 0378-0715-01 |
| NDC Item | 00378071501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0715-01) |
| ANDA | ANDA072668 |
| COLORTEXT | GREEN |
| Color | C48329 __ |
| FDA SPL set id | 610516 |
| Imprint code | M;715 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-06-08 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule-shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 0378-0715 |
NDC Item 13811062010
| NDC 9 | 13811-620 |
|---|---|
| NDC 10 | 13811-620-10 |
| NDC Item | 13811062010 |
| Packaging | 100 TABLET in 1 BOTTLE (13811-620-10) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 542380 |
| Imprint code | IT;72 |
| Labeler | Trigen Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-11-30 |
| Marketing effective time low | 2019-05-06 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 13811-620 |
NDC Item 16571022501
| NDC 9 | 16571-225 |
|---|---|
| NDC 10 | 16571-225-01 |
| NDC Item | 16571022501 |
| Packaging | 100 TABLET in 1 BOTTLE (16571-225-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 839159 |
| Imprint code | IT;72 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-12-10 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 16571-225 |
NDC Item 73152003101
| NDC 9 | 73152-031 |
|---|---|
| NDC 10 | 73152-031-01 |
| NDC Item | 73152003101 |
| Packaging | 100 TABLET in 1 BOTTLE (73152-031-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 630369 |
| Imprint code | IT;72 |
| Labeler | Athem LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 73152-031 |
NDC Item 00378071501
| NDC 9 | 0378-0715 |
|---|---|
| NDC 10 | 0378-0715-01 |
| NDC Item | 00378071501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0715-01) |
| ANDA | ANDA072668 |
| COLORTEXT | GREEN |
| Color | C48329 __ |
| FDA SPL set id | 610516 |
| Imprint code | M;715 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-06-08 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule-shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 0378-0715 |
NDC Item 13811062010
| NDC 9 | 13811-620 |
|---|---|
| NDC 10 | 13811-620-10 |
| NDC Item | 13811062010 |
| Packaging | 100 TABLET in 1 BOTTLE (13811-620-10) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 542380 |
| Imprint code | IT;72 |
| Labeler | Trigen Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-11-30 |
| Marketing effective time low | 2019-05-06 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 13811-620 |
NDC Item 16571022501
| NDC 9 | 16571-225 |
|---|---|
| NDC 10 | 16571-225-01 |
| NDC Item | 16571022501 |
| Packaging | 100 TABLET in 1 BOTTLE (16571-225-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 839159 |
| Imprint code | IT;72 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-12-10 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 16571-225 |
NDC Item 73152003101
| NDC 9 | 73152-031 |
|---|---|
| NDC 10 | 73152-031-01 |
| NDC Item | 73152003101 |
| Packaging | 100 TABLET in 1 BOTTLE (73152-031-01) |
| ANDA | ANDA207556 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 630369 |
| Imprint code | IT;72 |
| Labeler | Athem LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-14 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | capsule shaped |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 73152-031 |